{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470475254
| type              = mab
| image             = 
| alt               = 
| mab_type          = mab
| source            = zu
| target            = [[HIV-1]]
<!--Clinical data -->
| tradename         =  
| Drugs.com         =
| MedlinePlus       =
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      = <!-- A / B            / C / D / X -->
| pregnancy_category=  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration = 
<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         = 
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number        = 914257-21-9
| ATC_prefix        = none
| ATC_suffix        = 
| PubChem           = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank          = 
<!-- Chemical data -->
| chemical_formula  = 
| molecular_weight  = 

}}

'''Suvizumab''' is an antiviral and immunomodulator. It binds to [[HIV-1]].<ref>{{cite journal |title = Proposed List number 102 of International Nonproprietary Names|journal = WHO Drug Information|year = 2009|url = http://www.who.int/entity/medicines/publications/druginformation/innlists/PL_102.pdf|format = PDF|publisher = World Health Organization|location = Geneva|issn = 1010-9609|page = 344|volume = 23|issue = 4}}</ref>

== References ==
<references/>

{{monoclonals for infectious disease and toxins}}

[[Category:Monoclonal antibodies]]
[[Category:Experimental drugs]]


{{antiinfective-drug-stub}}
{{monoclonal-antibody-stub}}